Bio Architecture Lab shifts ops, becomes CRO; Astellas signs up with Accenture for IT;

> Bio Architecture Lab is shifting its strategy from renewable chemicals and fuels and becoming a full-fledged CRO. News

> Industry group ACRO is launching a new video series in which leaders from various industries tout the importance of clinical research. Item

> Astellas Pharma ($ALPMY) has signed an 8-year outsourcing agreement with IT heavyweight Accenture. Article

> Sponsors and CROs are working toward a model that improves oversight without micromanaging. Report

> Accelrys ($ACCL) has extended its long-standing partnership with Pfizer ($PFE) to provide R&D software. Story

> Scale-up Systems and ScienView are teaming up to provide process-development software to China's biopharmaceutical industry. More